logo-loader
viewTruTrace Technologies Inc

TruTrace Technologies and A&L Canada Labs team for testing of medical cannabis

TruTrace Technologies ((CSE: TTT; OTC: TTTSF) CEO Robert Galarza sat down with Steve Darling in the Vancouver studio of Proactive Investors to discuss the company, along with partner Shoppers Drug Mart, signing a deal with A&L Laboratories to run a pilot program.

Galarza telling Proactive that program will test the medical cannabis verification program, StrainSecure. 

Quick facts: TruTrace Technologies Inc

Price: 0.11 CAD

CSE:TTT
Market: CSE
Market Cap: $8.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of TruTrace Technologies Inc named herein, including the promotion by the Company of TruTrace Technologies Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TruTrace Technologies ramps up cannabis verification for...

TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) CEO Robert Galarza tells Proactive the technology company will be teaming up with telemedicine platform AdvancedCare, to expand throughout the medical cannabis space. Galarza says TrueTrace's StrainSecure technology, an integrated blockchain...

3 weeks, 5 days ago

2 min read